The S&P 500 dropped 0.3% on Wednesday, Feb. 12, as hotter-than-expected inflation data in the January CPI report weighed on the interest rate outlook.

Lenacapavir, developed by Gilead Sciences ... version of patented drugs without the patent holder’s consent in public health emergencies. For example, last year Colombia issued a compulsory ...

Lenacapavir, developed by Gilead Sciences ... version of patented drugs without the patent holder’s consent in public health emergencies. For example, last year Colombia issued a compulsory ...

BOGOTÁ, Colombia—The war over cocaine between armed ... to President Gustavo Petro’s plans to sign peace accords with drug-trafficking organizations. The violence, in which two groups have ...

He said Gilead expects to capitalize on its recent momentum with the expected launch this summer of lenacapavir for protecting against HIV infection. The U.S. Food and Drug Administration is ...

In addition, through the European Medicines Agency’s EU-Medicines for all program, Europe’s review of the drug can help speed up access in more than 100 countries, Gilead's chief commercial ...

President Donald Trump's executive order freezing foreign aid has dealt a blow to Colombia's military and police, weakening its ability to counter armed groups and drug trafficking organizations, ...

More than 32,000 people have fled to towns in northeast Colombia as they attempt to escape a sharp rise in fighting between militant factions, according to the country’s ombudsman. Iris Marín ...

A proposed law in Colombia's Congress seeks to ban the sale of merchandise that celebrates former drug lord Pablo Escobar, whose cocaine cartel has been linked to thousands of murders. One day in ...

Gilead could also have a twice-yearly version of Sunlenca (lenacapavir) on the way. It has completed regulatory filings in the U.S. and Europe for the HIV drug. Science magazine named lenacapavir ...